Journal
PEDIATRIC BLOOD & CANCER
Volume 66, Issue 3, Pages -Publisher
WILEY
DOI: 10.1002/pbc.27544
Keywords
hepcidin; inflammation; intravenous; nutritional; therapy
Categories
Ask authors/readers for more resources
Iron deficiency anemia remains a common referral to the pediatric hematology-oncology subspecialist. Improved understanding of iron homeostasis, including the effects of the regulatory hormone hepcidin, recent adult and pediatric clinical trial data, as well as the availability of safer formulations of intravenous iron, have resulted in additional considerations when making treatment recommendations in such patients. Young children and adolescent females remain the most commonly affected groups, but children with complex medical or chronic inflammatory conditions including comorbid gastrointestinal disorders also require special consideration.
Authors
I am an author on this paper
Click your name to claim this paper and add it to your profile.
Reviews
Recommended
No Data Available